Skip to main content
. 2024 Jul 25;16(15):2641. doi: 10.3390/cancers16152641

Table 3.

Detailed breakdown of surgical and chemotherapy interventions within adenosquamous carcinoma cohort, as well as data on recurrence, 5-year overall survival, and median survival.

Management
Surgery (n, %) 11 (84.6%)
Partial Colectomy 7 (58.3%)
Total Colectomy 3 (23.1%)
Low Anterior Resection 1 (7.7%)
Chemotherapy (n, %) 11 (84.6%)
Adjuvant only 8 (61.5%)
Neoadjuvant only 1 (7.7%)
Neoadjuvant and Adjuvant 2 (15.4%)
Clinical Outcomes
Recurrence (n, %) 7 (58.3%)
Locoregional 4 (30.8%)
Distant 3 (23.1%)
5-year overall survival 38.5%
Stage III 33.3%
Stage IV 33.3%
Median overall survival (months) 39.4
Stage III 30.5
Stage IV 23.7